Mayo Clinic has released an evidence-based framework to help clinicians manage menopausal symptoms in women with cardiovascular disease or elevated risk [1].
This guidance is critical because menopause-specific factors can complicate heart health, requiring doctors to balance symptom relief with cardiovascular safety.
In a recent expert interview, Dr. Chrisandra Shufelt said the necessity of individualizing care for these patients is critical [1]. The framework focuses on patient selection and the identification of specific cardiovascular risk factors associated with menopause [1]. By utilizing current data on hormone therapy, the initiative aims to provide clinicians with the tools to counsel patients with greater confidence [1].
Dr. Marysia Tweet hosted the discussion, which was produced by the Mayo Clinic [1]. The primary goal is to educate medical providers on how to navigate the intersection of endocrine changes and heart disease, a complex area of medicine where one-size-fits-all treatments may be inappropriate [1].
The framework emphasizes the importance of evidence-based decision-making when prescribing hormone therapy [1]. Clinicians are encouraged to evaluate the specific risk profile of each woman to determine if the benefits of symptom management outweigh the potential cardiovascular risks [1].
This approach seeks to bridge the gap between gynecological health and cardiology [1]. By standardizing the way clinicians assess these overlapping risks, the Mayo Clinic intends to improve long-term health outcomes for women entering menopause with pre-existing heart conditions [1].
“The framework focuses on patient selection and the identification of specific cardiovascular risk factors.”
The integration of cardiovascular risk assessment into menopause management represents a shift toward multidisciplinary care. By providing a standardized framework, the Mayo Clinic is addressing a historical gap in women's health where hormone replacement therapy and heart disease management were often treated as separate concerns.
